Lipid Nanoparticles with Side-Chain Polymer Coating for Targeted mRNA Delivery through Nanobody Attachment
Bioconjugate Chemistry · 15.04.2026 · 37 (4) · 684-692
DOI: 10.1021/acs.bioconjchem.6c00045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 26.03.2026. Verfasst von On Ting Choy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Liposomes, Nanoparticles, RNA, Messenger. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Australian Research Council, University of Queensland.
Abstract (Originalsprache)
The use of mRNA therapies has innovated the clinical progress of cancer immunotherapy. However, current immunotherapeutic approaches are unable to achieve site- or immune-cell-specific delivery, resulting in adverse immune responses in off-target tissues. In addition, the commercial lipid nanoparticle (LNP) formulations with a poly(ethylene glycol) coating generally undergo significant hepatic accumulation during clearance. To promote site- and immune-cell-specific delivery of therapeutic mRNA-LNPs, we investigated several bioconjugation approaches to attach targeting antibodies onto the surface of polymer-functionalized mRNA-LNPs. Building on our previous work, side-chain sulfoxide polymer–lipid conjugate PMSEA-DSPE was used to incorporate a low-fouling polymeric LNP coating. trans-Cyclooctene functionality was incorporated within PMSEA-DSPE end groups to allow conjugation to the tetrazine-functionalized nanobody 9G8 for EGFR targeting. Bioconjugation methods were compared, including direct conjugation and post-insertion. The results showed that 9G8-attached PMSEA mRNA-LNPs prepared via direct conjugation significantly enhanced cell association and in vitro transfection efficiency with an EGFR-positive cell line, demonstrating the potency of active targeting for mRNA-LNP platforms with side-chain polymer coatings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia.
- ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals, The University of Queensland, Brisbane, Queensland 4072, Australia.
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia.
- Australian Research Council Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide, The University of Queensland, Brisbane, Queensland 4072, Australia.
ORCID-Profile: On Ting Choy, Nicholas L Fletcher, Pie Huda, Craig A Bell, David J Owen, Andrew K Whittaker
Förderung
- Australian Research Council
- University of Queensland
Zitieren
APA
Choy, O. T., Fletcher, N. L., Huda, P., Bell, C. A., Owen, D. J., & Whittaker, A. K. (2026). Lipid Nanoparticles with Side-Chain Polymer Coating for Targeted mRNA Delivery through Nanobody Attachment. Bioconjugate Chemistry, 37(4), 684-692. https://doi.org/10.1021/acs.bioconjchem.6c00045
Vancouver
Choy OT, Fletcher NL, Huda P, Bell CA, Owen DJ, Whittaker AK. Lipid Nanoparticles with Side-Chain Polymer Coating for Targeted mRNA Delivery through Nanobody Attachment. Bioconjugate Chemistry. 2026;37(4):684-692. doi:10.1021/acs.bioconjchem.6c00045
BibTeX
@article{Choy2026,
author = {Choy, On Ting and Fletcher, Nicholas L and Huda, Pie and Bell, Craig A and Owen, David J and Whittaker, Andrew K},
title = {Lipid Nanoparticles with Side-Chain Polymer Coating for Targeted mRNA Delivery through Nanobody Attachment},
journal = {Bioconjugate Chemistry},
year = {2026},
volume = {37},
number = {4},
pages = {684--692},
doi = {10.1021/acs.bioconjchem.6c00045}
}
EUVIMED